![]() |
市场调查报告书
商品编码
1843381
2021-2031 年北美止咳糖市场报告(范围、细分、动态和竞争分析)North America Cough Drops Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
北美止咳糖市场预计将大幅成长,到 2031 年将达到约 9.1014 亿美元,高于 2023 年的 5.8021 亿美元,在此期间的年复合成长率(CAGR) 为 5.8%。
执行摘要和市场分析
北美止咳糖市场呈现稳定成长态势,这主要得益于消费者对呼吸系统健康的意识不断增强,以及感冒和流感症状的增多,尤其是在季节变化期间。市场提供种类繁多的产品,包括薄荷醇类、草本类和无醣类止咳糖,以满足不同消费者的偏好。美国凭藉其庞大的人口、高昂的医疗支出以及强大的零售网络,占据了市场主导地位。利口乐 (Ricola)、豪氏 (Halls)(亿滋国际)和 Luden's 等主要品牌正在积极创新,推出新口味并添加维生素 C 和锌等功能性成分,以满足不断变化的消费者需求。电子商务的成长以及人们对天然和有机产品的日益青睐,进一步丰富了市场产品种类。此外,新冠疫情 (COVID-19) 疫情加剧了人们对免疫力的关注,导致对治疗性润喉糖的需求增加。随着人们对预防性医疗保健和健康的兴趣日益浓厚,预计北美止咳糖市场在未来几年将继续保持上升趋势。
市场区隔分析
北美止咳药市场可按产品类型、应用和配销通路细分:
市场展望
感冒和流感等常见呼吸道疾病是导致喉咙痛症状的重要因素。根据世界卫生组织统计,全球每年约有10亿例季节性流感病例,其中300万至500万例为重症病例。症状通常在感染后1-4天出现,并可持续约一週。普通感冒、流感和季节性过敏的流行推动了对止咳产品的需求,因为消费者希望能够立即缓解咳嗽和咽喉刺激等症状。
快速城市化导致空气品质恶化,引发了人们对呼吸健康的担忧,导致呼吸系统疾病病例增加。污染物会加剧气喘和支气管炎等疾病,促使消费者寻求止咳药物来缓解症状。由于免疫力下降和现有的健康问题,老龄人口特别容易患上呼吸系统疾病。世界卫生组织预测,到 2030 年,全球每 6 人中就有 1 人年龄在 60 岁或以上,预计到 2050 年 80 岁及以上人口的数量将增加两倍。随着年龄的增长,人们更容易患上需要症状管理的慢性疾病,包括使用止咳药。慢性肺部疾病和免疫抑制发生率的上升导致老年人呼吸道感染增加。因此,在呼吸系统疾病负担日益加重的推动下,製造商正在创新其产品线并建立合作伙伴关係以扩大市场份额。
国家洞察
北美止咳糖市场包括美国、加拿大和墨西哥,其中美国在2023年占最大市场份额。美国市场的发展受到消费者偏好变化和对健康保健日益增长的关注的驱动。感冒和过敏等呼吸系统疾病的日益流行,导致非处方止咳和咽喉舒缓产品的需求激增。消费者越来越青睐天然和草药疗法,促使製造商不断创新,推出包含草药萃取物、维生素和精油的产品。例如,2021年10月,HALLS与体育解说员乔·巴克合作推出了HALLS minis无糖止咳糖。电子商务改变了止咳糖的购买格局,为消费者提供了更大的可及性和便利性。与传统零售店相比,线上平台允许产品比较、评论和更广泛的选择。呼吸系统疾病的季节性高峰推动了销售,消费者纷纷购买止咳产品,行销策略利用社群媒体和线上广告来吸引年轻族群。
公司简介
北美止咳糖市场的主要参与者包括 Bliss GVS Pharma Ltd、Cipla Ltd、Gepach International、葛兰素史克公司 (GSK Plc)、亿滋国际 (Mondelez International Inc)、利洁时集团 (Reckitt Benckiser Group Plc)、利口乐 (Ricola)、赛诺菲 (Sanofixer这些公司正在采取各种策略,包括扩张、产品创新和併购,以增强产品线并提高市场份额。
The North America Cough Drops Market is projected to grow significantly, reaching approximately US$ 910.14 million by 2031, up from US$ 580.21 million in 2023, with a compound annual growth rate (CAGR) of 5.8% during this period.
Executive Summary and Market Analysis
The cough drops market in North America has shown steady growth, primarily due to increased consumer awareness about respiratory health and a rise in cold and flu symptoms, especially during seasonal changes. This market offers a wide range of products, including menthol-based, herbal, and sugar-free cough drops, catering to diverse consumer preferences. The United States dominates the market, benefiting from a large population, significant healthcare expenditures, and a robust retail network. Major brands such as Ricola, Halls (Mondelez), and Luden's are actively innovating by introducing new flavors and incorporating functional ingredients like vitamin C and zinc to meet evolving consumer demands. The growth of e-commerce and a rising preference for natural and organic products have further diversified the market offerings. Additionally, the COVID-19 pandemic has heightened the focus on immunity, leading to increased demand for therapeutic lozenges. With a growing interest in preventive healthcare and wellness, the North America cough drops market is expected to continue its upward trajectory in the coming years.
Market Segmentation Analysis
The North America cough drops market can be segmented by product type, application, and distribution channel:
Market Outlook
Common respiratory issues such as colds and influenza are significant contributors to sore throat symptoms. According to the World Health Organization, around 1 billion cases of seasonal influenza occur globally each year, with 3-5 million cases classified as severe. Symptoms typically manifest 1-4 days post-infection and can last about a week. The prevalence of the common cold, flu, and seasonal allergies drives demand for cough relief products as consumers seek immediate alleviation from symptoms like coughing and throat irritation.
Deteriorating air quality due to rapid urbanization has raised concerns about respiratory health, leading to increased cases of respiratory illnesses. Pollutants exacerbate conditions such as asthma and bronchitis, prompting consumers to seek cough drops for relief. The aging population is particularly susceptible to respiratory disorders due to weakened immunity and existing health issues. The World Health Organization projects that by 2030, 1 in 6 individuals globally will be aged 60 or older, with the number of people aged 80 and above expected to triple by 2050. As individuals age, they are more likely to experience chronic illnesses that necessitate symptom management, including the use of cough drops. The rising incidence of chronic lung diseases and immunosuppression is contributing to increased respiratory infections among older adults. Consequently, manufacturers are innovating their product lines and forming partnerships to expand their market presence, driven by the growing burden of respiratory diseases.
Country Insights
The North America cough drops market includes the US, Canada, and Mexico, with the US holding the largest market share in 2023. The US market is driven by changing consumer preferences and a heightened focus on health and wellness. The increasing prevalence of respiratory conditions, such as colds and allergies, has led to a surge in demand for over-the-counter cough and throat-soothing products. Consumers are increasingly favoring natural and herbal remedies, prompting manufacturers to innovate with products that include herbal extracts, vitamins, and essential oils. For example, in October 2021, HALLS launched HALLS minis Sugar-Free Cough Drops in collaboration with sportscaster Joe Buck. E-commerce has transformed the purchasing landscape for cough drops, providing consumers with greater accessibility and convenience. Online platforms allow for product comparisons, reviews, and a wider selection than traditional retail stores. Seasonal peaks in respiratory illnesses drive sales as consumers stock up on cough relief products, with marketing strategies leveraging social media and online advertising to engage younger demographics.
Company Profiles
Key players in the North America cough drops market include Bliss GVS Pharma Ltd, Cipla Ltd, Gepach International, GSK Plc, Mondelez International Inc, Reckitt Benckiser Group Plc, Ricola, Sanofi SA, The Procter & Gamble Co, and Thornton & Ross. These companies are pursuing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their offerings and increase market share.